Lunt Capital Management’s Health Catalyst HCAT Stock Holding History

Lunt Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,337	Closed	-$22K	–	95
2026 Q1	$22K	Hold	17,337	–	–	0.01%	97
2025 Q4	$41.4K	Hold	17,337	–	–	0.02%	98
2025 Q3	$49.4K	Hold	17,337	–	–	0.02%	93
2025 Q2	$65.4K	Hold	17,337	–	–	0.03%	90
2025 Q1	$78.5K	Hold	17,337	–	–	0.03%	86
2024 Q4	$123K	Hold	17,337	–	–	0.05%	82
2024 Q3	$141K	Hold	17,337	–	–	0.07%	90
2024 Q2	$111K	Hold	17,337	–	–	0.05%	88
2024 Q1	$131K	Hold	17,337	–	–	0.06%	88
2023 Q4	$161K	Hold	17,337	–	–	0.08%	84
2023 Q3	$175K	Hold	17,337	–	–	0.09%	76
2023 Q2	$217K	Buy	+17,337	New	+$206K	0.12%	76

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lunt Capital Management's HCAT Position: Q2 2026 in Review

Lunt Capital Management sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 17,337 shares — an estimated $22K sold.

Lunt Capital Management first reported a position in HCAT in Q2 2023 and held it in 12 quarters. The position peaked at $217K in Q2 2023. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

Lunt Capital Management reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
Lunt Capital Management sold 17,337 Health Catalyst shares in Q2 2026, an estimated $22K.
Lunt Capital Management first reported a position in Health Catalyst in Q2 2023 and held it in 12 quarters.
Lunt Capital Management's Health Catalyst position peaked at $217K in Q2 2023.
126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Lunt Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.